Rare
lephants
Screener
Toggle theme
Vaso Corporation
VASO
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2017
FY2016
FY2015
FY2014
FY2012
FY2011
Total Cash from Operations:
$5.9M
Line Item
Value
% of Total
Other Investing
$0
0.0%
Other Financing
$122.5K
2.1%
Working Capital
$556.0K
9.5%
Other
$5.2M
88.4%
Net Cash Flow
$0
0.0%
Download CSV
